What Happened to In re: Blue Cross Blue Shield Antitrust Litigation MDL 2406 (Subscriber Settlement)?
The Blue Cross Blue Shield Antitrust Litigation resulted in a $2.67 billion settlement for subscribers who alleged the insurers engaged in anti-competitive practices, leading to higher premiums. After years of litigation and appeals, initial payments to eligible claimants began in May 2026, with approximately $1.9 billion distributed to about six million approved claims.
Quick Answer
Payments from the $2.67 billion Blue Cross Blue Shield antitrust settlement, stemming from a class-action lawsuit alleging anti-competitive practices, began distribution to eligible subscribers in May 2026. Approximately $1.9 billion is being disbursed to about six million approved claimants who filed by the November 2021 deadline. Individual payment amounts vary based on factors like coverage duration and premiums paid.
📊Key Facts
📅Complete Timeline13 events
Start of Class Period for Fully Insured Plans
The class period for individuals and insured groups covered by Blue Cross Blue Shield health insurance or administrative services plans began.
Class-Action Lawsuit Initiated and Consolidated
Plaintiffs filed a class-action lawsuit against Blue Cross Blue Shield, alleging antitrust violations. The cases were consolidated as 'In re: Blue Cross Blue Shield Antitrust Litigation MDL 2406' in the U.S. District Court for the Northern District of Alabama.
Start of Class Period for Self-Funded Accounts
The class period for self-funded accounts (typically employers) that purchased administrative service plans from Blue Cross Blue Shield began.
Preliminary Settlement Agreement Reached
Blue Cross Blue Shield Association and Settling Individual Blue Plans reached a preliminary settlement agreement for $2.67 billion to resolve the antitrust allegations. This also marked the end of the class periods.
Claim Filing Deadline
The deadline for eligible class members to submit a valid claim to receive a payment from the settlement fund passed.
Final Approval of Subscriber Settlement Granted
U.S. District Judge R. David Proctor granted final approval to the $2.67 billion subscriber settlement.
Appeals Court Affirms Settlement
The Eleventh Circuit Court of Appeals unanimously affirmed the subscriber settlement, rejecting challenges to the agreement.
Supreme Court Denies Further Appeals
The U.S. Supreme Court declined to hear further challenges to the settlement, affirming the agreement as final and clearing the way for distribution.
Final Approval of Provider Settlement Granted
A separate $2.8 billion antitrust settlement for healthcare providers against Blue Cross Blue Shield received final court approval.
Provider Settlement Claim Notices Issued
The Settlement Claims Administrator for the separate Blue Cross Blue Shield Provider Settlement began issuing claim notices to eligible healthcare providers.
Motion for Fund Distribution Approved
A motion for the distribution of settlement funds for the subscriber settlement was filed on April 23, 2026, and approved by the court on April 24, 2026.
Initial Subscriber Settlement Payments Begin
The initial distribution of payments to Damages Class Members with valid claims from the $2.67 billion subscriber settlement began.
Payments Ongoing and Notices Sent
As of today, payments are actively being distributed to approved claimants, and claim determination notices are being sent on a rolling basis via email or postcard. Distributions are expected to continue throughout late spring and summer.
🔍Deep Dive Analysis
The 'In re: Blue Cross Blue Shield Antitrust Litigation MDL 2406' is a landmark class-action lawsuit that accused the Blue Cross Blue Shield Association and its member companies of violating antitrust laws by agreeing not to compete with one another in certain geographic markets. This alleged scheme, which began as early as 2008, purportedly limited consumer choice and resulted in higher health insurance premiums for millions of Americans. The litigation, consolidated in 2013 in the U.S. District Court for the Northern District of Alabama, involved more than 35 Blue Cross Blue Shield affiliates.
Blue Cross Blue Shield denied the allegations throughout the legal process, maintaining that its business practices fostered lower healthcare costs and broader access to care. However, to avoid the significant costs and uncertainties of continued litigation, the parties reached a preliminary settlement agreement in October 2020. This agreement included a total settlement fund of $2.67 billion, alongside injunctive relief aimed at modifying certain business practices, such as enabling large self-funded national employers to request a 'Second Blue Bid' from a different Blue Cross Blue Shield company.
Following the preliminary agreement, the settlement underwent a lengthy approval process. Judge R. David Proctor granted final approval in August 2022. Appeals were subsequently filed, but the Eleventh Circuit Court of Appeals unanimously affirmed the settlement in October 2023. The U.S. Supreme Court then declined to hear further challenges on June 24, 2024, clearing the final legal hurdles and allowing the distribution process to move forward.
As of May 2026, the settlement administrator began the initial distribution of payments to Damages Class Members with valid claims, specifically starting on May 11, 2026. After deducting attorneys' fees (approximately $667 million) and administrative costs, the net settlement fund available for direct distribution to eligible claimants is roughly $1.9 billion. Approximately six million valid claims were submitted by the November 5, 2021, deadline. Payments are being issued via paper check, prepaid debit card, or electronic methods like PayPal or Venmo, with individual amounts varying based on factors such as the duration of coverage and premiums paid during the class periods (February 2008 to October 2020 for fully insured, and September 2015 to October 2020 for self-funded accounts).
This settlement represents one of the largest private antitrust settlements in U.S. history where no government agency had prosecuted or participated. While individual payments may be modest, the case is expected to have long-term implications for competition and pricing practices within the health insurance industry. A separate $2.8 billion settlement for healthcare providers also received final approval in August 2025, with claim notices issued in February 2026 and payments anticipated in 2026, bringing the total antitrust resolution against BCBS to over $5.4 billion.
What If...?
Explore alternate histories. What if In re: Blue Cross Blue Shield Antitrust Litigation MDL 2406 (Subscriber Settlement) made different choices?